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Abstract
Background: Congenital heart defects are the leading non-infectious cause of death in children.
Genetic studies in the mouse have been crucial to uncover new genes and signaling pathways
associated with heart development and congenital heart disease. The identification of murine
models of congenital cardiac malformations in high-throughput mutagenesis screens and in gene-
targeted models is hindered by the opacity of the mouse embryo.
Results: We developed and optimized a novel method for high-throughput multi-embryo magnetic
resonance imaging (MRI). Using this approach we identified cardiac malformations in
phosphatidylserine receptor (Ptdsr) deficient embryos. These included ventricular septal defects,
double-outlet right ventricle, and hypoplasia of the pulmonary artery and thymus. These results
indicate that Ptdsr plays a key role in cardiac development.
Conclusions: Our novel multi-embryo MRI technique enables high-throughput identification of
murine models for human congenital cardiopulmonary malformations at high spatial resolution. The
technique can be easily adapted for mouse mutagenesis screens and, thus provides an important
new tool for identifying new mouse models for human congenital heart diseases.
Background
Congenital malformations are a major cause of death in
childhood, and are typically characterized by lesions that
do not compromise fetal survival. For instance, congenital
heart disease (CHD) typically consists of lesions such as
ventricular and atrial septal defects, which are compatible
with fetal hemodynamics [1]. Although human genetic
studies have identified some genes that cause congenital
cardiac malformations, the molecular and developmental
mechanisms underlying most of these defects remain
largely unknown. Despite the high incidence of CHD
(~1% of live births), only a handful of genes have been
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identified that when mutated, result in congenital heart
disease [2-4].
The mouse is a particularly good model for studying
mechanisms of cardiac diseases as its anatomy and devel-
opment resembles that of the human more closely than
any other genetically tractable organism. Importantly, the
mouse is amenable to genotype-driven approaches such
as transgenic knockouts of defined candidate genes [5],
genome wide mutagenesis approaches using gene-trap [6]
or transposon insertion screens [7], and high-throughput
phenotype-driven screens that rely, for instance, on N-
ethyl-N-nitrosourea (ENU) mutagenesis [8,9]. However,
high-throughput cardiovascular genomic approaches in
the mouse have been hampered by the paucity of pheno-
typing tools that allow efficient identification of complex
cardiac malformations. As mouse embryos are opaque,
late developmental defects are particularly difficult to
identify. For instance, cardiac septal defects or outflow
tract abnormalities can only be confidently identified
after 14.5 days post coitum (dpc) when cardiac and out-
flow tract septation are completed in normal embryos.
The identification of malformations in late gestation
embryos typically relies on serial histological sectioning,
which is extremely labor intensive. Furthermore, this
often results in the irretrievable loss of 3D information,
which is essential for the interpretation of complex car-
diac malformations. In addition, standard pathological
analysis is not amenable to high-throughput phenotype
screening protocols that are required for any mutagenesis
screen aiming at the functional dissection of the develop-
mental biology of cardiac diseases. Therefore, new techno-
logical approaches must be harnessed that allow an
efficient phenotyping of heart defects and also of subtle
cardiac abnormalities that are at danger of being overseen
in traditional histopathology screens. This is even more
important in the light of upcoming new endeavors in
functional mouse genome annotation [10]. Currently,
new large-scale mouse mutagenesis screens are being set
up in the US and in Europe that aim to produce heritable
mutations in every gene in the mouse genome [11-13]. To
make full use of these new mouse mutant resources more
precise and efficient phenotyping methods are urgently
needed [12-14]. The success of genome wide saturation
mutagenesis screens depends therefore on improved phe-
notyping, and new high-resolution imaging approaches
for mouse mutants are one of the most important which
need to be established.
We previously reported the development of fast gradient-
echo MRI of single mouse embryos [15-17]. This resulted
in the acquisition of a 3D dataset in under 9 hours, with
an experimental image resolution of 25 × 25 × 26 µm/
voxel. We showed that MRI is capable of accurately iden-
tifying normal embryonal structures, and cardiac and
adrenal malformations in knockout mouse embryos, and
we have validated this technique by performing in depth
histological examinations of imaged embryos [15-17].
These experiments showed that single-embryo MRI could
correctly identify all cardiac lesions (atrial septal defects,
ventricular septal defects, outflow tract defects such as
double-outlet right ventricle, and aortic arch defects)
except those under 20 µm – which is below the resolution
of the MRI technique. As this method images single
embryos in overnight runs, it still lacks the throughput
required for phenotype-driven mutagenesis screens. For
instance, in a typical recessive ENU mutagenesis screen, to
screen 50 ENU mutant lines using a 3-generation breeding
scheme would require the analysis of ~1200 embryos
[18]. We now report the development of a method of
imaging up to 32 embryos simultaneously in a single
unattended overnight run, at high spatial resolution.
Allowing ~30 minutes per embryo, the analysis of 1200
embryos would take 75 working days for a single trained
individual. We show that this high-throughput multi-
embryo MRI technique can be used to rapidly identify
unsuspected embryonal cardiac and visceral malforma-
tions. Using this technique we could identify a novel, and
hitherto unsuspected role for the phosphatidylserine
receptor (Ptdsr) in controlling ventricular septal, outflow
tract and pulmonary artery development. In addition, we
found thymus hypoplasia in Ptdsr-deficient embryos.
These findings suggest that a novel Ptdsr-mediated path-
way is required for cardiac and thymus development.
Results
Multi-embryo imaging
We modified our previously described fast gradient echo
magnetic resonance imaging technique [15-17] to image
embryos embedded in four to eight layers (16 – 32
embryos total) in 28 mm nuclear magnetic resonance
tubes using a single quadrature driven birdcage coil (Fig-
ure 1a). Preparation and embedding of embryos typically
took less than an hour. In initial experiments we imaged
up to 16 embryos simultaneously in overnight runs of <9
hours, with an experimental resolution of 51 × 51 × 39
µm. Subsequently, we used a custom made optimized
probe with an increased sensitivity range to enhance
imaging throughput. This allowed us to image 32
embryos simultaneously (Figure 1a,b), but with a larger
matrix size and an increased field-of-view in the long axis
of the tube. For these experiments we imaged embryos for
~12 hours, and achieved an improved experimental reso-
lution of 43 × 43 × 36 µm. The optimized coil used for 32
embryos MRI (Figure 1) has a sensitivity range in z-direc-
tion of close to 50 mm. The artefacts seen at both ends in
the longitudinal image (Figure 1b) are caused by B1-inho-
mogeneities at the end-rings of the coil. However, accu-
rate image analysis for the entire data set remains possible
if the height of the embryo stack does not exceedBMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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approximately 47 mm as demonstrated in the corre-
sponding axial views of the top and the bottom layer (Fig-
ure 1c,d). The resolution achieved with the multi-embryo
MRI technique allowed us to visualize the heart, cardiac
septa, central nervous system, and visceral organs in fine
detail (Figure 1d–f), in embryos taken from each layer.
The data are permanently archived on DVDs, for subse-
quent analysis. Construction of 3D reconstructions of the
heart typically takes ~4 hours, but was not necessary for
the identification of cardiovascular defects.
Sensitivity and specificity of multi-embryo imaging
To assess the sensitivity and specificity of multi-embryo
imaging in comparison to single-embryo imaging, we
used a model of Cited2 deficiency [19]. Embryos lacking
Cited2  (Cited2-/-) have diverse cardiac malformations,
including atrial and ventricular septal defects, outflow
tract and aortic arch malformations, and adrenal agenesis
[15,17,19]. As the Trp53-repressor gene Cdkn2aP19ARF is a
target of Cited2 [20], we also examined embryos lacking
both Cited2 and Trp53 to determine if this would rescue
the heart and adrenal defects in Cited2-/- mice. We imaged
50 embryos using the multi-embryo technique in the 16-
embryo mode. Embryonal genotypes included 12 wild-
type, 13 Cited2+/-, 14 Cited2-/-, three Cited2-/-: Trp53-/-, four
Cited2-/-: Trp53+/-, two Trp53+/-, and two Trp53-/-. We ana-
lyzed the data from each embryo for cardiac malforma-
tions without knowledge of the genotype. This typically
took a maximum of 30 minutes per embryo. We scored
each embryo for atrial and ventricular septal defects (ASD,
VSD), outflow tract (e.g. double-outlet right ventricle,
common arterial trunk), and aortic arch malformations
(e.g. right-sided or bilateral aortic arch, retroesophageal
subclavian artery), and for adrenal agenesis. Each embryo
was then re-imaged singly at high resolution, and the data
re-analyzed as before. In this group we identified 20
embryos with ASD, 19 with VSD, 18 with outflow tract
defects, 11 with aortic arch defects, and 21 with bilateral
adrenal agenesis, using high-resolution single embryo
imaging. In comparison to single embryo imaging, the
overall sensitivity and specificity of multi-embryo imag-
ing for cardiac malformations was 88% and 92% respec-
tively. For ASD (18 identified by single embryo imaging)
the sensitivity and specificity was 85% and 95%; for VSD
94% and 94%; for outflow tract malformations 94% and
100%; and for aortic arch malformations 91% and 100%
High-throughput high-resolution magnetic resonance microscopy Figure 1
High-throughput high-resolution magnetic resonance microscopy. (a) Stack of 32 embryos embedded in a NMR 
tube. (b) Section through the long axis of the NMR tube showing embryos in eight layers. (c) Sagittal section through layer 8 
showing the four embryos in this layer. (d–f) Transverse, sagittal, and coronal sections through individual embryos in layers 5, 
1 and 4 respectively. The voxel size is 25.4 × 25.4 × 24.4 µm. Structures indicated are the spinal cord (sc), the right and left 
lungs, atria and ventricles (rl, ll, ra, la, rv, lv), primary atrial and interventricular septa (pas, ivs), mitral valve (mv), midbrain roof 
(mbr), midbrain (mb), mesencephalic vesicle (mes), thalamus (tha), hypothalamus (hy), pons (po), cerebellum (c), medulla 
oblongata (mo), pituitary (pit), tongue (t), thymus (th), left superior vena cava and main bronchus (lsvc, lmb), aorta (ao), liver 
(li), stomach (s), left adrenal and kidney (lad, lk), pancreas (pa), intestines (i), umbilical hernia (uh), aqueduct of Sylvius (aq), 
fourth ventricle (fv), inner ear (ie), larynx (lar), right ventricular outflow tract (rvot), spleen (sp), and testes (te). Scale bars = 
500 µm; axes: d – dorsal; v – ventral; r – right; l – left; a – anterior, p – posterior.BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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respectively (Figure 2). For bilateral adrenal agenesis, the
sensitivity was 100% and specificity was 95% (Figure 3).
Embryos lacking both Cited2 and Trp53 had cardiovascu-
lar defects and adrenal agenesis, indicating that Trp53
does not play a major role in the genesis of these defects
in mice lacking Cited2. These results indicate that multi-
embryo MRI is a potentially powerful high-throughput
tool for efficiently characterizing cardiovascular malfor-
mations and identifying other defects in organogenesis.
Cardiac malformations in mice lacking Ptdsr
We next evaluated the role of multi-embryo MRI in ana-
lyzing unexplained lethality in embryos generated in col-
laborating laboratories. Recently, we have generated mice
lacking the phosphatidylserine receptor (Ptdsr-/-) on a C57BL/
6J background, by gene targeting in embryonic stem cells
[21]. Ptdsr is a nuclear protein of unknown function,
which is essential for the development and differentiation
of multiple organs during embryogenesis [21-24].
Identification of septal, outflow tract, and aortic arch malformations using multi-embryo MRI Figure 2
Identification of septal, outflow tract, and aortic arch malformations using multi-embryo MRI (a – e') Images of 
transverse sections from 5 Cited2-/- embryos obtained using the multi-embryo technique (a–e) compared with images from the 
same embryos obtained subsequently using the single embryo technique (a'–e'). (a, a') Section showing left and right atria and 
ventricles (la, ram, live, rave). The atria are separated by the primary atria septum (pas), which is deficient at its ventral margin 
creating an osmium premium type of atria septal defect (ASD-P). (b, b') Section showing a ventricular septal defect (VSD) in 
the interventricular septum (ivs). (c, c') Section showing double outlet right ventricle, wherein the ascending aorta (a-ao) and 
the pulmonary artery (pa) both arise from the right ventricle (rv). The aortic valve (ao-v) is indicated. (d, d') Section showing a 
right-sided aortic arch (ao-a) passing to the right of the trachea (tr) and the esophagus (es). (e, e') Section showing bilateral 
aortic arches (ao-a) forming a vascular ring around the trachea (tr) and the esophagus (es). Also indicated are the thymus (th) 
and the right superior vena cava (r-svc). (f – j) Serial transverse sections through a wild-type heart obtained using single 
embryo MRI, demonstrating corresponding normal structures, including the systemic venous sinus (svs), left superior vena cava 
(l-svc), pulmonary vein (pvn), descending aorta (d-ao), mitral and tricuspid valves (mv, tv), the secondary atrial septum (sas), left 
and right ventricular outflow tracts (lvot, rvot), pulmonary valve (pv), and arterial duct (ad) of the pulmonary artery. Scale bars 
= 635 µm for multi-embryo, and 317 µm for single embryo images; axes: d – dorsal; v – ventral; r – right; l – left.BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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Ablation of Ptdsr function in knockout mice causes peri-
natal lethality, growth retardation [21,22,24] and a delay
in terminal differentiation of the kidney, intestine, liver
and lungs during embryogenesis [21]. In addition, Ptdsr-/-
embryos develop complex ocular lesions [21] as well as
haematopoietic defects [24]. However, as many malfor-
mations have been described in Ptdsr mutants, none of
those detected could explain the observed perinatal
lethality of Ptdsr-/- mice. In the process of phenotypical
characterization of our Ptdsr-deficient mouse line, we fre-
quently observed subcutaneous edema of varying sizes in
Ptdsr-/- embryos by gross inspection ([21] and Figure 4). As
the development of edema in various mouse mutants is
frequently associated with cardiovascular defects [25] we
started to investigate if this also holds true for Ptdsr-defi-
cient mice. We examined 8 embryos lacking Ptdsr, and 8
littermate wild-type or heterozygous controls using multi-
embryo MRI. We found that 5 of 8 Ptdsr-/- embryos had
cardiac malformations, which included ventricular septal
defects, double outlet right ventricle, and pulmonary
artery hypoplasia (Figure 5). None of the wild-type or
Ptdsr+/- embryos had cardiac malformations. These find-
ings were confirmed on single embryo imaging (Figure 6).
Furthermore, to verify the identified cardiac defects in the
Ptdsr-/- mice we performed serial transverse sectioning of
all analyzed embryos. In all cases, we could recognize
again the same heart defects that were identified before
using the multi-embryo MRI technique (Figure 7). In
addition, we analyzed by multi-embryo MRI a second
Ptdsr-knockout mouse line (Ptdsrtm1.1 Gbf), which is identi-
cal to the initially analyzed Ptdsr mutant except that the
loxP-flanked neomycin selection cassette was removed by
breeding the original Ptdsrtm1 Gbf knockout line [21] to a
CMV-Cre deleter mouse line [26]. From this Ptdsrtm1.1 Gbf
knockout mouse line we analyzed 8 Ptdsr-/- embryos, and
as littermate controls, 3 Ptdsr+/+ and 1 Ptdsr+/- embryos. We
found ventricular septal defects in five out of the eight
Ptdsr-/- embryos (data not shown). Again we found no evi-
dence for cardiac malformations in wild-type or hetero-
zygous littermate control embryos.
We also observed a modest degree of thymic hypoplasia in
Ptdsr-/- embryos (Figure 6k). To confirm this, thymus and
embryo volumes were measured in 8 Ptdsr-/- embryos and
8 wild-type or heterozygous control embryos at 15.5 dpc.
Embryo volume measured from the MRI datasets corre-
lated very strongly with embryo weight (Figure 6l), and
was modestly reduced in Ptdsr-/- embryos (Figure 6m). The
volume of the thymus was significantly reduced in Ptdsr-/-
embryos, even after correction for embryo volume, to
58% of the control value (Figure 6n,o). To correlate the
identified cardiopulmonary malformations in Ptdsr-/-
embryos with expression of the Ptdsr gene during heart
development, we made use of our Ptdsr gene-trap reporter
mouse line [21]. Using X-Gal staining in heterozygous
embryos staged between 9.5 dpc and 12.5 dpc we found
specific Ptdsr expression in the heart starting at 10.5 dpc
and getting more defined to the compact zone and the
trabeculi from 11.5 dpc onwards (Figure 8). Furthermore,
when we analyzed Ptdsr-/- hearts by histopathology at 16.5
dpc we observed a severe differentiation defect in the com-
pact zone as well as in the trabeculi (Figure 9), thus dem-
onstrating that Ptdsr  is in addition required for heart
muscle differentiation at later stages of development.
Taken together these results indicate that Ptdsr  plays a
hitherto unsuspected role in cardiovascular development
as well as in cardiac muscle differentiation.
Discussion
Utility of MRI in identifying mouse models of human 
malformations
Our results show that it is possible to efficiently identify
and quantitate relatively subtle cardiac and visceral mal-
formations in late gestation mouse embryos using multi-
Identification of adrenal agenesis using multi-embryo MRI Figure 3
Identification of adrenal agenesis using multi-embryo 
MRI Images of coronal sections from 2 embryos obtained 
using the multi-embryo technique (a, b) compared with 
images from the same embryos obtained subsequently using 
the single embryo technique (a', b'). (a, a') Normal right 
adrenal gland (rad) anterior to the right kidney (rk) in a wild-
type embryo. The right lung (rl) is indicated. (b, b') Agenesis 
of right adrenal gland in a Cited2-/- embryo. Scale bars = 635 
µm for multi-embryo, and 317 µm for single embryo images; 
axes: d – dorsal; v – ventral; a – anterior, p – posterior.BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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Edema in Ptdsr-/- mice Figure 4
Edema in Ptdsr-/- mice (a) The Ptdsr-/- mutant (15.5 dpc) is growth retarded and the severe edema along the back of the 
embryo is visible. (b, c) Sagital sections of embryos at 16.5 dpc. The mutant embryo (c) exhibits massive subcutaneous edema 
compared to a wild-type (b) littermate. Scale bar = 100 µm in (b) and (c).BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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embryo MRI. We have deliberately optimized our
technique at late gestation in order to identify those con-
genital defects that allow survival through most of gesta-
tion. Importantly, these defects resemble human
congenital malformations, and would provide mouse
models for the study of these diseases. Our method repre-
sents a simpler alternative to the multi-coil approach pub-
lished recently [27,28] in which up to eight fixed mouse
embryos were imaged simultaneously, with a resolution
of 200 µm. In comparison, the multi-embryo method
described here has a higher experimental resolution of 43
µm. Notably, it requires substantial developmental and
financial effort to equip an experimental MR-system with
multiple coil and receive capability.
Role of MRI in investigating murine embryonal or perinatal 
lethality
Many mouse gene knockouts display late gestational
lethality, but incomplete analysis and loss of 3D
information consequent to histological sectioning, results
in major developmental malformations being frequently
missed. As shown here, Ptdsr-/- embryos on a C57BL/6J
background develop heart defects. This was not noted in
recent reports [22,24], and emphasizes the need not only
for completely examining several mutant embryos, but
also repeating these examinations in different genetic
backgrounds. A major advantage of MRI is the ability to
easily ship fixed embryos from referring laboratories to
the laboratory that performs the MRI analysis. This mini-
mizes the expense of animal relocation, re-derivation, and
breeding required to generate the embryos, and signifi-
cantly reduces animal experimentation.
Role of MRI in high-throughput phenotype driven screens
MRI screens performed at late gestation would be
expected to identify genes that affect later aspects of devel-
opment, and identify hypomorphic and haploinsufficient
alleles of genes that affect earlier steps of development.
Published data from genome-wide ENU mutagenesis
screens in the mouse indicate that ~30% progeny carry a
heritable recessive phenotype, making 3-generation reces-
sive screens the method of choice for identifying develop-
mental malformations [18]. At least 24 3rd generation
progeny per 1st generation mutant are typically screened,
resulting in a >78% probability of identifying at least one
fully penetrant recessive homozygous mutant. A typical
recessive screen (e.g. 50 – 100 first generation mutants per
year) would require the analysis of ~1200 – 2400 embryos
per year. Our results show that multi-embryo MRI is emi-
nently suitable for such throughput. Although, screening
of 32 embryos overnight requires typically about 16 hours
of data analysis, multi-embryo MRI mutagenesis screens
can be easily performed at a reasonable scale if multiple
operators analyze the data in parallel. As the data are
Identification of cardiac malformations in Ptdsr-/- embryos using multi-embryo MRI Figure 5
Identification of cardiac malformations in Ptdsr-/- embryos using multi-embryo MRI (a–e) Transverse thoracic sec-
tions showing the heart of heterozygous or wild-type control embryos from each litter. The left and right ventricles (lv, rv) are 
separated by the interventricular septum (ivs). The left and right atria (la, ra) are also indicated, separated by the primary atrial 
septum (pas). (f–i) Corresponding sections through littermate Ptdsr-/- embryos, showing ventricular septal defects (VSD). Scale 
bar = 635 µm; axes: d – dorsal; v – ventral; r – right; l – left; a – anterior, p – posterior. Individual embryos are indicated by 
number.BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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permanently stored on DVDs, and can be analyzed easily
by commercially available software, they can be without
difficulty disseminated to specialists for further and more
detailed analysis. Another powerful application of multi-
embryo MRI will likely be the investigation and screening
of potentially teratogenic drugs.
Functional role of Ptdsr in heart development
Our results presented here indicate a new, and hitherto
unsuspected role for the phosphatidylserine receptor in
controlling ventricular septal, outflow tract, pulmonary
artery, and thymus development. This finding suggests
that a novel Ptdsr-mediated pathway is required for
Cardiac malformations and thymus hypoplasia in Ptdsr-/- embryos Figure 6
Cardiac malformations and thymus hypoplasia in Ptdsr-/- embryos. (a–c) Transverse and oblique (through the plane of 
the ascending aorta) sections, and 3D reconstruction (left-ventral oblique view) of a heart of a wild-type embryo at 15.5 dpc. 
The left and right ventricles (lv, rv) are separated by the interventricular septum (ivs). The left and right atria (la, ra), and the 
trachea (tr) are also indicated. The ascending aorta (a-ao) arises from the left ventricular outflow tract (lvot), via the aortic 
valve (ao-v), and continues on as the aortic arch (ao-a), which joins the descending aorta (d-ao). The pulmonary artery (pa) 
arises from the right ventricular outflow tract (rvot), and continues as the arterial duct (ad), which joins the descending aorta. 
(d–f) Corresponding images of a Ptdsr-/- embryo, showing a smaller heart with a ventricular septal defect (VSD). The aorta 
arises from the right ventricle. The pulmonary artery is small and its connection to the descending aorta (arterial duct) could 
not be identified. (g–i) Corresponding images of another Ptdsr-/- embryo, showing a ventricular septal defect (VSD). The aorta 
overrides the VSD resulting in a double-outlet right ventricle. (j, k) Coronal sections of Ptdsr+/+ and Ptdsr-/- embryos, showing 
the two lobes of the thymus (th). The arterial duct of the pulmonary artery in the Ptdsr-/- embryo is narrowed. (l) Correlation 
between embryo weight and volume. Scattergram of embryo weight versus embryo volume measured from multi-embryo MRI 
datasets for 16 embryos using Amira. The co-efficient of regression (r) is indicated. (m, n,) Absolute embryo and thymus vol-
umes (µl) were measured from the MRI datasets from 5 wild-type (wt), 3 heterozygote (h), and 8 Ptdsr-/- (m) embryos at 15.5 
dpc. There was no significant difference in the wild-type and heterozygote data, which were therefore pooled together (wt/h). 
(o) Relative thymus volumes (% of embryo volume) were calculated as Ptdsr-/- embryos were slightly smaller than littermate 
wild-type embryos. The data are represented as mean ± S.D. The probability of a type I error (P) is indicated. Scale bars = 317 
µm; axes: r – right; l – left; d – dorsal; v – ventral; a – anterior, p – posterior. Individual embryos are indicated by number.BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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Cardiac malformations in Ptdsr-/- embryos: analysis using histology Figure 7
Cardiac malformations in Ptdsr-/- embryos: analysis using histology Embryos analyzed by MRI (Figure 3) were sec-
tioned transversely and stained with hematoxylin and eosin. (a–c) Serial caudal to cranial sections of the wild-type embryo 
showing normal cardiac and vascular anatomy. The left and right ventricles (lv, rv) are separated by the interventricular septum 
(ivs). The ascending aorta (a-ao) arises from the left ventricle, continues on as the aortic arch (ao-a), which joins the descend-
ing aorta (d-ao). The pulmonary artery (pa) arises from the right ventricle via the pulmonary valve (pv) and continues as the 
arterial duct (ad), which joins the descending aorta. The left and right atria (la, ra), trachea (tr), right main bronchus (rmb) and 
esophagus (es) are indicated. (d) Section through embryo 33 indicating the ventricular septal defect (VSD). (e, f) Sections 
through embryo 55 showing that both aorta and pulmonary artery arise from the right ventricle (double outlet right ventricle), 
and that the arterial duct of the pulmonary artery is narrow in comparison to the aorta – indicating pulmonary artery hypopla-
sia. The aortic valve (aov) is indicated. (g–i) Serial caudal to cranial sections through embryo 35 showing a VSD, aorta arising 
from the right ventricle (double outlet right ventricle), and a severely narrowed arterial duct. Scale bars = 500 µm; axes: r – 
right; l – left; d – dorsal; v – ventral. Individual embryos are indicated by number.BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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cardiac and thymus development. Recently, we have dem-
onstrated that in contrast to previously reported hypothet-
ical Ptdsr functions, the Ptdsr protein is not required for
the clearance of apoptotic cells [21]. Moreover, detailed
analysis of apoptosis induction and apoptotic cell clear-
ance in Ptdsr+/+ and Ptdsr-/- embryos during heart develop-
ment did not reveal any difference in the number and
location of apoptotic cells between the genotypes (J.B.,
A.D.G. and A.L. unpublished observations). This further
excludes that Ptdsr has any function in apoptotic cell
clearance and points to other developmental mechanisms
that are affected by Ptdsr ablation. The neural crest plays
an important role in the development of the cardiac out-
flow tract, aortic arches, and the thymus [29]. As Ptdsr-
deficient embryos lack intestinal ganglia [21] which are
also derived from the neural crest, these results suggest
that  Ptdsr-/- mice may have an underlying neural crest
defect. Importantly, dysfunction of these Ptdsr-mediated
pathways during development could also potentially
result in heart defects in humans.
Conclusions
Our results validate the utility of multi-embryo MRI for
high-throughput identification of murine models for
human congenital cardiac malformations, and using this
technique we have shown that Ptdsr is essential for normal
cardiac development. Further experiments are needed to
define exactly in which pathways Ptdsr is involved during
heart development. We expect that multi-embryo MRI
will be an important technology for future phenotype-
driven mouse mutagenesis screens. The technology can be
easily implemented at standard MRI imaging centers, thus
allowing by collaboration with individual researchers or
mouse mutagenesis centers, a high-throughput functional
genetic dissection of mechanisms underlying cardiac
development and congenital heart diseases.
Methods
Mice
Cited2-/- [19], Trp53-/- [30], and Ptdsr-/- mice [21] have been
described previously. All embryos were harvested at 15
days after detection of the vaginal plug.
Embryo preparation
Embryos were fixed in 4% paraformaldehyde at 4°C for
~1 week, and then embedded in 1% agarose (Seakem)
containing 2 mM gadolinium-diethylenetriamine pen-
taacetic anhydride (Gd-DTPA, Magnevist, Schering UK) in
28 mm nuclear magnetic resonance tubes (Figure 1). The
left forelimb was removed from each embryo to facilitate
the identification of the left side. In addition, embryos
had other limbs and/or tails removed before embedding
so that each embryo in a given layer (of four embryos)
could be unequivocally identified.
Magnetic resonance imaging
Single embryo imaging was performed as described previ-
ously [15-17]. For multi-embryo imaging, we used the
same 11.7 Tesla (500 MHz) vertical magnet (Magnex Sci-
entific, Oxon, UK). This was interfaced to a Bruker Avance
console (Bruker Medical, Ettlingen, Germany) equipped
with a shielded gradient system with a maximal gradient
strength of 548 mTesla/m (Magnex Scientific, Oxon, UK),
and quadrature-driven birdcage type coils with an inner
diameter of 28 mm (Rapid Biomedical, Würzburg, Ger-
many). Compressed air at room temperature was used to
reduce the heating induced by the gradients. A 3D spoiled
gradient echo sequence (echo time 10 ms), a π/2 excita-
tion pulse with rectangular pulse shape, (π/2 = 100 µs),
was used with a short repetition time (30 ms) to obtain
strong T1 contrast. A matrix size of 512 × 512 × 768 (band-
width: 130 Hz/pixel) at a field of view of 26 × 26 × 30 mm
achieved an experimental resolution of 51 × 51 × 39 µm
when imaging up to 16 specimens. In case of 32 embryos,
a matrix size of 608 × 608 × 1408 at field of view of 26 ×
26 × 50 mm, yielded an experimental resolution of 43 ×
43 × 36 µm. The total experimental time was ~8.75 hours
for 16 embryos, and ~12.3 hours for 32 embryos (typi-
cally overnight runs) whereby each phase encoding step
was averaged four times.
Data reconstruction and analysis
The raw MR data were reconstructed into a stack of 1024
(for 16 embryos), or 2048 (for 32 embryos) 2D TIFF files
(16 bit pixel resolution, 2 or 4 GB total size) using pur-
pose-written software as described previously [16]. The
TIFF files were analyzed using Amira 3.1(TGS Europe,
Mérignac Cedex, France). 3D reconstructions were
performed using the Image Segmentation Editor, and tis-
Analysis of Ptdsr expression in the embryonic heart Figure 8
Analysis of Ptdsr expression in the embryonic heart 
(a, b) Staining of heterozygous Ptdsr-βgeo-embryos [21] using 
X-Gal at 10.5 dpc (a) and 11.5 dpc (b). (a) At 10.5 dpc Ptdsr 
expression can be seen throughout the heart. (b) Transverse 
sections of X-Gal stained embryos at 11.5 dpc showed an 
increased expression of Ptdsr in the myocardial wall and a 
beginning decrease of the expression in the trabeculation. 
Scale bar = 100 µm in (b).BMC Developmental Biology 2004, 4:16 http://www.biomedcentral.com/1471-213X/4/16
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sue volumes for morphometric analysis were measured
using the Measure Tissue Statistics tool available in Amira
3.1. The probability (p) of a Type I error was calculated
using a 2-sample equal variance 2-tailed t-test in Microsoft
Excel.
Histology
Embryos were dehydrated in ethanol, embedded in paraf-
fin wax, and sections were stained with hematoxylin and
eosin.
X-Gal staining of embryos
Embryos were dissected free of extraembryonic mem-
branes and then fixed in 4% paraformaldehyde at 4°C.
Expression of Ptdsr was detected by staining the embryos
overnight in X-Gal according to standard protocols. The
embryos were postfixed in 4% paraformaldehyde and
processed for documentation or histology.
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